Trials / Sponsors / Alessandro Doria
Alessandro Doria
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1 | Phase 3 | 2024-10-31 |
| Active Not Recruiting | A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes Diabetic Nephropathies | Phase 2 | 2022-01-04 |
| Completed | A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Diabetic Nephropathies, Coronary Artery Disease | Phase 3 | 2014-02-01 |